SUCLA2 mutations cause global protein succinylation contributing to the pathomechanism of a hereditary mitochondrial disease

Research output: Contribution to journalJournal articleResearchpeer-review

  • Philipp Gut
  • Sanna Matilainen
  • Jesse G. Meyer
  • Pieti Pällijeff
  • Joy Richard
  • Christopher J. Carroll
  • Liliya Euro
  • Christopher B. Jackson
  • Pirjo Isohanni
  • Berge A. Minassian
  • Reem A. Alkhater
  • Gabriele Civiletto
  • Alice Parisi
  • Jonathan Thevenet
  • Matthew J. Rardin
  • Wenjuan He
  • Yuya Nishida
  • John C. Newman
  • Xiaojing Liu
  • Stefan Christen
  • Sofia Moco
  • Jason W. Locasale
  • Birgit Schilling
  • Anu Suomalainen
  • Eric Verdin

Mitochondrial acyl-coenzyme A species are emerging as important sources of protein modification and damage. Succinyl-CoA ligase (SCL) deficiency causes a mitochondrial encephalomyopathy of unknown pathomechanism. Here, we show that succinyl-CoA accumulates in cells derived from patients with recessive mutations in the tricarboxylic acid cycle (TCA) gene succinyl-CoA ligase subunit-β (SUCLA2), causing global protein hyper-succinylation. Using mass spectrometry, we quantify nearly 1,000 protein succinylation sites on 366 proteins from patient-derived fibroblasts and myotubes. Interestingly, hyper-succinylated proteins are distributed across cellular compartments, and many are known targets of the (NAD+)-dependent desuccinylase SIRT5. To test the contribution of hyper-succinylation to disease progression, we develop a zebrafish model of the SCL deficiency and find that SIRT5 gain-of-function reduces global protein succinylation and improves survival. Thus, increased succinyl-CoA levels contribute to the pathology of SCL deficiency through post-translational modifications.

Original languageEnglish
Article number5927
JournalNature Communications
Volume11
Issue number1
ISSN2041-1723
DOIs
Publication statusPublished - 2020

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 261153419